Elutia (ELUT) Stock: Buy, Sell, or Hold?
ELUT - Elutia Inc. Class A Common Stock
$0.78
-0.02 (-2.66%)
▼
5d:
-5.01%
30d:
-7.89%
90d:
-17.84%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When ELUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ELUT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ELUT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ELUT is currently trading at $0.78, which is considered oversold relative to its 30-day fair value range of $0.79 to $0.90.
Technical Outlook: Technically, ELUT is in a strong downtrend. Immediate support is located at $0.67, while resistance sits at $0.90.
Market Sentiment: ELUT scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.00 (+542.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELUT is in a strong downtrend. Immediate support is located at $0.67, while resistance sits at $0.90.
Market Sentiment: ELUT scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.00 (+542.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.79 -
$0.90
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 542.1% below Wall St target ($5.00)
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.79 -
$0.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.67
Resistance Level
$0.90
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.44
Wall Street Target
$5.00
(+542.1%)
Revenue Growth (YoY)
-11.6%
Profit Margin
426.9%
Share & Embed Analysis
Last updated: October 04, 2026 2:16 AM ET
Data refreshes hourly during market hours. Next update: 3:16 AM
Data refreshes hourly during market hours. Next update: 3:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELUT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 38 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$83 | 60 BUY |
